| 000 | 01810 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516215847.0 | ||
| 264 | 0 | _c20140926 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2014.307 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, W | |
| 245 | 0 | 0 |
_aThe association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJul 2014 |
||
| 300 |
_a628-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xmortality |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMerriman, K | |
| 700 | 1 | _aNabaah, A | |
| 700 | 1 | _aSeval, N | |
| 700 | 1 | _aSeval, D | |
| 700 | 1 | _aLin, H | |
| 700 | 1 | _aWang, M | |
| 700 | 1 | _aQazilbash, M H | |
| 700 | 1 | _aBaladandayuthapani, V | |
| 700 | 1 | _aBerry, D | |
| 700 | 1 | _aOrlowski, R Z | |
| 700 | 1 | _aLee, M-H | |
| 700 | 1 | _aYeung, S-C J | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 111 _gno. 3 _gp. 628-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2014.307 _zAvailable from publisher's website |
| 999 |
_c23911951 _d23911951 |
||